Abstract:It is now clear that major malignancies are heterogeneous diseases associated with diverse molecular properties and clinical outcomes, posing a great challenge for more individualized therapy. In the last decade, cancer molecular subtyping studies were mostly based on transcriptomic profiles, ignoring heterogeneity at other (epi-)genetic levels of gene regulation. Integrating multiple types of (epi)genomic data generates a more comprehensive landscape of biological processes, providing an opportunity to better dissect cancer heterogeneity. Here, we propose sparse canonical correlation analysis for cancer classification (SCCA-CC), which projects each type of single-omics data onto a unified space for data fusion, followed by clustering and classification analysis. Without loss of generality, as case studies, we integrated two types of omics data, mRNA and miRNA profiles, for molecular classification of ovarian cancer ( n = 462), and breast cancer ( n = 451). The two types of omics data were projected onto a unified space using SCCA, followed by data fusion to identify cancer subtypes. The subtypes we identified recapitulated subtypes previously recognized by other groups (all P - values < 0.001), but display more significant clinical associations. Especially in ovarian cancer, the four subtypes we identified were significantly associated with overall survival, while the taxonomy previously established by TCGA did not ( P- values: 0.039 vs. 0.12). The multi-omics classifiers we established can not only classify individual types of data but also demonstrated higher accuracies on the fused data. Compared with iCluster, SCCA-CC demonstrated its superiority by identifying subtypes of higher coherence, clinical relevance, and time efficiency. In conclusion, we developed an integrated bioinformatic framework SCCA-CC for cancer molecular subtyping. Using two case studies in breast and ovarian cancer, we demonstrated its effectiveness in identifying biologically meaningful and clinically relevant subtypes. SCCA-CC presented a unique advantage in its ability to classify both single-omics data and multi-omics data, which significantly extends the applicability to various data types, and making more efficient use of published omics resources.

MRGCN: cancer subtyping with multi-reconstruction graph convolutional network using full and partial multi-omics dataset

MoGCN: A Multi-Omics Integration Method Based on Graph Convolutional Network for Cancer Subtype Analysis

Molecular Subtyping of Cancer Based on Robust Graph Neural Network and Multi-Omics Data Integration

A Multimodal Graph Neural Network Framework of Cancer Molecular Subtype Classification

Attention-based GCN integrates multi-omics data for breast cancer subtype classification and patient-specific gene marker identification

Multi-layer matrix factorization for cancer subtyping using full and partial multi-omics dataset

Multi-view contrastive clustering for cancer subtyping using fully and weakly paired multi-omics data

A multimodal graph neural network framework for cancer molecular subtype classification

MMGCN: Multi-modal multi-view graph convolutional networks for cancer prognosis prediction

Cancer subtype identification by consensus guided graph autoencoders

Comparative Analysis of Multi-Omics Integration Using Advanced Graph Neural Networks for Cancer Classification

Supervised Graph Clustering for Cancer Subtyping Based on Survival Analysis and Integration of Multi-Omic Tumor Data

PCA-constrained multi-core matrix fusion network: A novel approach for cancer subtype identification

Subtype-GAN: a deep learning approach for integrative cancer subtyping of multi-omics data

Multi-relational Multi-View Clustering and Its Applications in Cancer Subtype Identification

Multi-Omics Data Fusion for Cancer Molecular Subtyping Using Sparse Canonical Correlation Analysis

A Contrastive-Learning-Based Deep Neural Network for Cancer Subtyping by Integrating Multi-Omics Data

Multimodal Survival Ensemble Network: Integrating Genomic and Histopathological Insights for Enhanced Cancer Prognosis.

MDICC: novel method for multi-omics data integration and cancer subtype identification

A classification method of gastric cancer subtype based on residual graph convolution network

Subtype-WGME enables whole-genome-wide multi-omics cancer subtyping